Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Democritus University of Thrace
Age
18–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
be diagnosed and classified as stage 1 keratoconus according to the Amsler-Krumeich classification system for keratoconus
present progressive keratoconus in consecutive corneal topographies, and/or changes in their refractive power.
Progressive keratoconus was defined when any of the following criteria was met for a period of 24 months:
an increase of 1.00 diopter (D) or more in the steepest keratometry measurement
an increase of 1.00 D or more in manifest cylinder
an increase of 0.50 D or more in manifest refraction spherical equivalent.
You may not be if
glaucoma
suspicion for glaucoma
IOP-lowering medications
central corneal thickness (CCT) less than 400μm
K-readings more than 60D
history of herpetic keratitis
corneal scarring
severe eye dryness
pregnancy or nursing
current corneal infection
or underlying autoimmune disease KG members were further sub-divided into CxL and tCxL groups, according to their eligibility for treatment with CxL or CxL with tPRK. In order to be eligible for tCxL, group participants should, additionally, have CCT above 450μm.